美股新聞 標題聯播 · 近 24 小時 283 則 · 25 個來源 · 最新 9/20 07:00
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · MIST近 30 天 5 則 · 第 1 / 1 頁
- Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States
- Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
- Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes
- Milestone Pharmaceuticals shares rise as first patient enters Phase 3 AFib trial
- Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)
- Milestone Pharmaceuticals Inc. Q2 2026 Earnings Call Summary
- Milestone Pharmaceuticals Q2 Earnings Call Highlights
- Milestone Pharmaceuticals (MIST) Reports Q2 Loss, Lags Revenue Estimates
- Milestone Pharmaceuticals shares tumble after Q2 earnings miss
- Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
- Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026
- After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Milestone Pharmaceuticals (MIST)
- Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Milestone (MIST) Q1 2026 Earnings Transcript
- Paroxysmal Supraventricular Tachycardia Market Analysis Report 2026-2036, Profiles of Leading Players - Medtronic, Boston Scientific, Abbott Laboratories, Milestone Pharmaceuticals, Sanofi, Pfizer
- Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Path To Profitability
- Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
- Milestone Pharmaceuticals Inc. Q1 2026 Earnings Call Summary
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。